Yoshio Sakurai
Cancer Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshio Sakurai.
Archive | 1976
Takao Iwaguchi; Yoshio Sakurai
Intraperitoneal administration of OK-432 prolonged life span of CDF1 mice bearing P388. Cell-mediated immune response of the host was investigated in vitro with the method of electrophoretic mobility of macrophage. At the early stage of tumor development, the cell-mediated immune response of the host treated with OK-432 was kept stronger than that of the untreated one. However, at the advanced stage of tumor development, there was little difference in the cell mediated immune response between both groups. The host was found to be more immunosuppressed than that at the early stage of tumor development.
GANN Japanese Journal of Cancer Research | 1965
Mahmoud M. El-MERZABANI; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1965
Mahmoud M. El-MERZABANI; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1972
Michiko Aoshima; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1967
Mahmoud M. El-MERZABANI; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1971
Michiko Aoshima; M. Ishidate; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1970
Takao Iwaguchi; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1973
Michiko Aoshima; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1973
Mahmoud Mohamed El-Merzabani; Hiroko Ichimura; Hiroshi Satoh; Yoshio Sakurai
GANN Japanese Journal of Cancer Research | 1973
Michiko Aoshima; Yoshio Sakurai